Back to VRTX
TRUIST FINANCIAL CORP VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
16
Latest value
$26.3M
Q3 2026
Peak value
$35.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $19.9M |
| Q3 2025 | $35.8M |
| Q3 2025 | $632K |
| Q3 2025 | $254K |
| Q4 2025 | $22.6M |
| Q4 2025 | $33.9M |
| Q4 2025 | $674K |
| Q1 2026 | $180K |
| Q1 2026 | $23M |
| Q1 2026 | $28M |
| Q2 2026 | $140K |
| Q2 2026 | $25.9M |
| Q2 2026 | $27.1M |
| Q3 2026 | $141K |
| Q3 2026 | $25.6M |
| Q3 2026 | $26.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $26.3M | 50.2K | — | — |
| Q3 2026 | $25.6M | 49.0K | — | — |
| Q3 2026 | $141K | 270 | — | — |
| Q2 2026 | $27.1M | 54.5K | — | — |
| Q2 2026 | $25.9M | 52.2K | — | — |
| Q2 2026 | $140K | 282 | — | — |
| Q1 2026 | $28M | 62.6K | — | — |
| Q1 2026 | $23M | 51.4K | — | — |
| Q1 2026 | $180K | 402 | — | — |
| Q4 2025 | $674K | 1.5K | — | — |
| Q4 2025 | $33.9M | 74.7K | — | — |
| Q4 2025 | $22.6M | 50.0K | — | — |
| Q3 2025 | $254K | 10.2K | — | — |
| Q3 2025 | $632K | 1.6K | — | — |
| Q3 2025 | $35.8M | 91.3K | — | — |
| Q3 2025 | $19.9M | 50.9K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B